Neurocrine Biosciences Inc
XBER:NB3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Neurocrine Biosciences Inc
XBER:NB3
|
US |
|
H
|
High Tide Inc
XBER:2LYA
|
CA |
|
Tantalus Systems Holding Inc
OTC:TGMPF
|
CA |
|
R
|
Rothschild & Co SCA
LSE:0FPB
|
FR |
|
E
|
Ebebek Magazacilik AS
IST:EBEBK.E
|
TR |
|
Evolution AB (publ)
STO:EVO
|
SE |
|
AUB Group Ltd
OTC:AUBBF
|
AU |
|
B
|
Bank Mandiri (Persero) Tbk PT
OTC:PPERY
|
ID |
|
W
|
WiseTech Global Ltd
F:17W
|
AU |
|
J
|
Julius Baer Gruppe AG
SIX:BAERE
|
CH |
Shareholder Yield
Current shareholder yield for 
NB3 is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
NB3 Price
Neurocrine Biosciences Inc
| Average Annual Return | 16.07% |
| Standard Deviation of Annual Returns | 22.73% |
| Max Drawdown | -48% |
| Market Capitalization | 15.9B EUR |
| Shares Outstanding | 60 879 804 |
| Percentage of Shares Shorted |
N/A
|
